학술논문
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India
Document Type
Article
Author
Source
In The Lancet Infectious Diseases July 2022 22(7):1052-1061
Subject
Language
ISSN
1473-3099